North America Ion Chromatography Mass Spectrometry Market – Industry Trends and Forecast to 2030

North America Ion Chromatography Mass Spectrometry Market, By Type (Systems, Software), Platform (Hybrid Mass Spectrometry, Single Mass Spectrometry, Other Platforms), Mode of Operation {(Single Ion Monitoring (SIM), Selected Reaction Monitoring (SRM), High Resolution Accurate Mass (HRAM)}, Work Flow (Electrospray Ionization (ESI), Atmospheric Pressure Chemical Ionization (APCI), Others), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Diagnostic Centers, Forensic Laboratories, Hospitals, Academic and Research Institutes,  Others), Distribution Channel (Direct Tender, Retail Sales – Industry Trends and Forecast to 2030.

North America Ion Chromatography Mass Spectrometry Market Analysis and Size

Market growth will quicken as a result of mass spectrometry's recent advances. The pharmaceutical and biotechnology industries all use ion chromatography mass spectrometry for a variety of purposes. It supports, among other things, process validation and clinical testing of pharmacokinetics, proteomics, biomarker development and environmental testing, quantitative drug analysis, and protein identification. The demand for the widespread usage of mass spectrometry in drug development has fuelled the market expansion.

Data Bridge Market Research analyses that the Ion chromatography mass spectrometry market which is USD 75.3715 million in 2022, is expected to reach USD 133.43 million by 2030, at a CAGR of 7.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Ion Chromatography Mass Spectrometry Market Scope and Segmentation  

Market Definition

The applications for ion chromatography mass spectrometry are used in the pharmaceutical and biotechnology sectors, including process validation, clinical testing of protein identification and quantitative drug analysis, pharmacokinetics, proteomics, biomarker discovery, environmental testing, and others.

North America Ion Chromatography Mass Spectrometry Market Dynamics

Drivers

• Rising usage of Ion chromatography mass spectrometry

Ion-exchange chromatography (IEX) is used in non-aqueous mobile phases to purify a non-crystalline intermediate after a reductive amination with D-xylose, strength and purity of the intermediate allowing successful downstream processing. According to a study published in March 2021 titled "Non-aqueous Ion-Exchange Chromatography Using High Acid-Base Concentration: A Strategy for Purifying Non-crystalline Pharmaceutical Intermediates." The market growth is anticipated to be driven by this procedure' importance in pharmaceutical manufacture because ion chromatography is widely used in the pharmaceutical sector.

• Rising funding for R&D

The Congressional Budget Office estimates that the National Institute of Health has received 700 billion dollars in federal funding over the last 20 years, which will be announced in April 2021. (NIH). With the help of this financing, novel disease pathways have been discovered in the fields of genomics, molecular biology, and other life sciences. The NIH has received more funding yearly, and in 2020, it will become 41 billion. Therefore, increased funding for basic research R&D will encourage the use of ion chromatography in R&D, resulting in market growth.

Opportunities

• Increasing advancements of mass spectrometry

The advancement of mass spectrometry in recent years will accelerate market growth. For instance, in May 2019, the FDA published a report describing a method for detecting six nitrosamine impurities present in ARB drugs. The high-mass accuracy (HRAM) mass spectrometer, also known as a high-resolution spectrometer, is the most effective method for determining the precise value of mass to charge ratio in deprotonated and protonated impurity ions. These FDA-approved methods or techniques are fuelling market demand for high-mass accuracy mass spectrometers (HRAM). Such legislation promotes the use of mass spectrometry in a wide range of industries, fuelling market growth in the near future.

Restraints/Challenges

• Scarcity of skilled professionals

The scarcity of skilled professionals capable of operating ion chromatography equipment will also hamper the market growth during the forecast period.

This Ion chromatography mass spectrometry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Ion chromatography mass spectrometry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2019, New mass spectrometry systems were released by the Waters Corporation to address complex analytical requirements. Two brand-new mass spectrometry systems have been put on the market: Cyclic IMS and SYNAPT XS. This business strengthened its product line while also enhancing its consumer offering.
• In 2019, Thermo Fisher Scientific Inc developed the Mass spectrometry (IC-MS/MS) analytical procedure, a new ion chromatography technique. The approach is designed to assist testing facilities in overcoming the difficulties associated with LC-MS/MS, or liquid chromatography tandem analysis with mass spectrometry. They enhanced their solutions for clients in the industry through this business.

North America Ion Chromatography Mass Spectrometry Market Scope

The Ion chromatography mass spectrometry market is segmented on the basis of type, platform, mode of operation, work flow, end-user and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Systems
• Software

Platform

• Hybrid Mass Spectrometry
• Single Mass Spectrometry
• Other Platforms

 Mode of Operation

• Single Ion Monitoring (SIM)
• Selected Reaction Monitoring (SRM)
• High Resolution Accurate Mass (HRAM)

 Work Flow

• Electrospray Ionization (ESI)
• Atmospheric Pressure Chemical Ionization (APCI)
• Others

 End User

• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organizations
• Diagnostic Centers
• Forensic Laboratories
• Hospitals
• Academic and Research Institutes
• Others

Distribution Channel

• Direct Tender
• Retail Sales

Ion Chromatography Mass Spectrometry Market Regional Analysis/Insights

The Ion chromatography mass spectrometry market is analyzed and market size insights and trends are provided by country, type, platform, mode of operation, work flow, end-user and application as referenced above.

The countries covered in the Ion chromatography mass spectrometry market report are U.S., Canada and Mexico in North America.

U.S. is dominating the market because of growing concern about pollution-free environments and high adoption of mass spectrometry in clinical tests, the market is expected to grow at a significant rate between 2023 and 2030.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The Ion chromatography mass spectrometry market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Ion chromatography mass spectrometry market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Ion chromatography mass spectrometry market. The data is available for historic period 2011-2021.

Competitive Landscape and Ion Chromatography Mass Spectrometry Market Share Analysis

The Ion chromatography mass spectrometry market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Ion chromatography mass spectrometry market.

Some of the major players operating in the Ion chromatography mass spectrometry market are:

• Axel Semrau GmbH & Co. KG (Germany)
• Bruker (U.S.)
• Cecil Instrumentation Services Ltd. (U.K.)
• General Electric (U.S.)
• Hitachi High-Tech America, Inc. (Japan)
• JASCO Corporation (Japan)
• KNAUER Wissenschaftliche Geräte GmbH (Germany)
• SEDERE (France)
• Sykam GmbH (Germany)
• Waters Corporation. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Scion Instruments (Netherlands)
• Gilson Incorporated. (U.S.)
• PerkinElmer Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Restek Corporation. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)